UB Paderborn / Katalog / Suche / in CDI

Special Issue: "Digestive Inflammation and New Therapeutical Targets"

International journal of molecular sciences, 2024-04, Vol.25 (8), p.4361

2024

Volltextzugriff (PDF)

Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging Target

Molecules (Basel, Switzerland), 2021-08, Vol.26 (16), p.4849

2021

Volltextzugriff (PDF)

The Orexin receptors: Structural and anti-tumoral properties

Frontiers in endocrinology (Lausanne), 2022-07, Vol.13, p.931970-931970

2022

Volltextzugriff (PDF)

Editorial: A year in review: discussions in molecular and structural endocrinology

Frontiers in endocrinology (Lausanne), 2023-06, Vol.14, p.1231470-1231470

2023

Volltextzugriff (PDF)

Efficiency of Orexin-A for Inflammatory Flare and Mucosal Healing in Experimental Colitis: Comparison with the Anti-TNF Alpha Infliximab

International journal of molecular sciences, 2023-05, Vol.24 (11), p.9554

2023

Volltextzugriff (PDF)

Class II G protein-coupled receptors for VIP and PACAP: Structure, models of activation and pharmacology

Peptides (New York, N.Y. : 1980), 2007-09, Vol.28 (9), p.1631-1639

2007

Volltextzugriff (PDF)

Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases

Frontiers in endocrinology (Lausanne), 2019-10, Vol.10, p.709-709

2019

Volltextzugriff (PDF)

The family B1 GPCR: structural aspects and interaction with accessory proteins

Current drug targets, 2012-01, Vol.13 (1), p.103

2012

Volltextzugriff (PDF)

Signal Transduction by VIP and PACAP Receptors

Biomedicines, 2022-02, Vol.10 (2), p.406

2022

Volltextzugriff (PDF)

Recurrent PRKAR1A Mutation in Acrodysostosis with Hormone Resistance

The New England journal of medicine, 2011-06, Vol.364 (23), p.2218-2226

2011

Volltextzugriff (PDF)

Characterizations of a synthetic pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular side effects in a Parkinson's disease model

Neuropharmacology, 2016-09, Vol.108, p.440-450

2016

Volltextzugriff (PDF)

Impact of Orexin-A Treatment on Food Intake, Energy Metabolism and Body Weight in Mice

PloS one, 2017-01, Vol.12 (1), p.e0169908-14

2017

Volltextzugriff (PDF)

Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation

Journal of neuroinflammation, 2019-03, Vol.16 (1), p.64-64, Article 64

2019

Volltextzugriff (PDF)

Novel Receptor Partners and Function of Receptor Activity-modifying Proteins

The Journal of biological chemistry, 2003-01, Vol.278 (5), p.3293-3297

2003

Volltextzugriff (PDF)

Functional Characterization of PRKAR1A Mutations Reveals a Unique Molecular Mechanism Causing Acrodysostosis but Multiple Mechanisms Causing Carney Complex

The Journal of biological chemistry, 2015-11, Vol.290 (46), p.27816-27828

2015

Volltextzugriff (PDF)

The Anti-tumoral Properties of Orexin/Hypocretin Hypothalamic Neuropeptides: An Unexpected Therapeutic Role

Frontiers in endocrinology (Lausanne), 2018-09, Vol.9, p.573-573

2018

Volltextzugriff (PDF)

Editorial: GPCR in Inflammatory and Cancer Diseases

Frontiers in endocrinology (Lausanne), 2020-09, Vol.11, p.588157-588157

2020

Volltextzugriff (PDF)

Class-B GPCR activation: is ligand helix-capping the key?

Trends in biochemical sciences (Amsterdam. Regular ed.), 2008-07, Vol.33 (7), p.314-319

2008

Volltextzugriff (PDF)

VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins

British journal of pharmacology, 2012-05, Vol.166 (1), p.42-50

2012

Volltextzugriff (PDF)

Molecular and Conformational Determinants of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) for Activation of the PAC1 Receptor

Journal of medicinal chemistry, 2009-05, Vol.52 (10), p.3308-3316

2009

Volltextzugriff (PDF)

Discovery of a functional immunoreceptor tyrosine-based switch motif in a 7-transmembrane-spanning receptor: role in the orexin receptor OX1R-driven apoptosis

The FASEB journal, 2009-12, Vol.23 (12), p.4069-4080

2009

Volltextzugriff (PDF)

In memoriam - Patrick Robberecht (1944–2023)

Peptides (New York, N.Y. : 1980), 2023-05, Vol.163, p.170977, Article 170977

2023

Volltextzugriff (PDF)

Identification by photoaffinity labeling of the extracellular N-terminal domain of PAC1 receptor as the major binding site for PACAP

Biochimie, 2011-04, Vol.93 (4), p.669-677

2011

Volltextzugriff (PDF)

Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions

World journal of gastroenterology : WJG, 2021-11, Vol.27 (44), p.7582-7596

2021

Volltextzugriff (PDF)

PACAP prevents toxicity induced by cisplatin in rat and primate neurons but not in proliferating ovary cells: Involvement of the mitochondrial apoptotic pathway

Neurobiology of disease, 2008-10, Vol.32 (1), p.66-80

2008

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Special Issue: "Digestive Inflammation and New Therapeutical Targets"

Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging Target

The Orexin receptors: Structural and anti-tumoral properties

Editorial: A year in review: discussions in molecular and structural endocrinology

Efficiency of Orexin-A for Inflammatory Flare and Mucosal Healing in Experimental Colitis: Comparison with the Anti-TNF Alpha Infliximab

Class II G protein-coupled receptors for VIP and PACAP: Structure, models of activation and pharmacology

Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases

The family B1 GPCR: structural aspects and interaction with accessory proteins

Signal Transduction by VIP and PACAP Receptors

Recurrent PRKAR1A Mutation in Acrodysostosis with Hormone Resistance

Characterizations of a synthetic pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular side effects in a Parkinson's disease model

Impact of Orexin-A Treatment on Food Intake, Energy Metabolism and Body Weight in Mice

Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation

Novel Receptor Partners and Function of Receptor Activity-modifying Proteins

Functional Characterization of PRKAR1A Mutations Reveals a Unique Molecular Mechanism Causing Acrodysostosis but Multiple Mechanisms Causing Carney Complex

The Anti-tumoral Properties of Orexin/Hypocretin Hypothalamic Neuropeptides: An Unexpected Therapeutic Role

Editorial: GPCR in Inflammatory and Cancer Diseases

Class-B GPCR activation: is ligand helix-capping the key?

VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins

Molecular and Conformational Determinants of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) for Activation of the PAC1 Receptor

Discovery of a functional immunoreceptor tyrosine-based switch motif in a 7-transmembrane-spanning receptor: role in the orexin receptor OX1R-driven apoptosis

In memoriam - Patrick Robberecht (1944–2023)

Identification by photoaffinity labeling of the extracellular N-terminal domain of PAC1 receptor as the major binding site for PACAP

Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions

PACAP prevents toxicity induced by cisplatin in rat and primate neurons but not in proliferating ovary cells: Involvement of the mitochondrial apoptotic pathway

Suchergebnisse filtern